Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.

Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007 Oct; 13(10):1250-5.

View in: PubMed

collapse authors with profiles